The FDA has approved a new Alzheimer’s treatment called donanemab, marketed as Kisunla by Eli Lilly. This approval marks the third drug in a new class aimed at slowing brain decline in early-stage Alzheimer’s patients. Approval and Availability After years…
A new study has found that some antidepressants are more likely to cause weight gain than others. This research tracked weight changes in patients using eight popular antidepressant drugs. Study Details The study was published in the Annals of Internal…
Rising Prescription Drug Costs: A Significant Burden for Americans The cost of prescription drugs in the U.S. has surged nearly 40% over the past decade, greatly outpacing inflation, according to a new study by GoodRx, a drug savings company. The…
